Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

3.3%

6 terminated/withdrawn out of 180 trials

Success Rate

84.6%

-1.9% vs industry average

Late-Stage Pipeline

16%

28 trials in Phase 3/4

Results Transparency

18%

6 of 33 completed trials have results

Key Signals

44 recruiting6 with results

Enrollment Performance

Analytics

N/A
46(45.1%)
Phase 2
19(18.6%)
Phase 4
18(17.6%)
Phase 3
10(9.8%)
Phase 1
6(5.9%)
Early Phase 1
3(2.9%)
102Total
N/A(46)
Phase 2(19)
Phase 4(18)
Phase 3(10)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (180)

Showing 20 of 180 trials
NCT07643922Not ApplicableNot Yet Recruiting

Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Role: collaborator

NCT06902740Phase 4Recruiting

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Role: collaborator

NCT07645209Active Not Recruiting

A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07129148Not ApplicableRecruiting

Mobile Health and Wearable Devices for Diabetes Complication Management

Role: collaborator

NCT06544083Recruiting

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Role: collaborator

NCT07524699Not ApplicableNot Yet Recruiting

A Study About Remote and Local Liver Surgery

Role: collaborator

NCT05788029Not ApplicableEnrolling By Invitation

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

Role: collaborator

NCT06274411Not ApplicableRecruiting

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

Role: collaborator

NCT03385902Not ApplicableCompleted

Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation

Role: collaborator

NCT06928376Phase 2Recruiting

A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients

Role: collaborator

NCT07569055Recruiting

Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT07540741Recruiting

Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke

Role: lead

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT05029141Phase 2Active Not Recruiting

New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT07209787Phase 4Recruiting

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Role: collaborator

NCT07466251Phase 4Not Yet Recruiting

PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke

Role: collaborator